- Tenet’s 2025 net operating revenue forecast ranges from $20.60 billion to $21.00 billion, below the estimate of $21.24 billion.
- The adjusted EBITDA forecast is between $3.98 billion and $4.18 billion, aligning closely with the estimate of $4.04 billion.
- Tenet’s adjusted EPS forecast is set between $11.74 and $12.84, surpassing the estimate of $11.11.
- Fourth quarter results revealed adjusted EBITDA of $1.05 billion, exceeding the estimate of $1.01 billion.
- Ambulatory Care’s net operating revenue was $1.26 billion, higher than the estimated $1.19 billion.
- Hospital Operations and Services’ net operating revenue was $3.81 billion, falling short of the estimated $3.98 billion.
- Net operating revenue for the fourth quarter was $5.07 billion, slightly below the estimate of $5.14 billion.
- Adjusted EPS for the fourth quarter reached $3.44, significantly above the estimated $2.81.
- The FY 2025 adjusted EBITDA outlook is projected between $3.975 billion and $4.175 billion.
- Analyst recommendations include 17 buys and 5 holds, with no sells.
Tenet Healthcare on Smartkarma
Analyst coverage of Tenet Healthcare on Smartkarma reveals bullish sentiment from Baptista Research with their report titled “Tenet Healthcare Corporation: Expansion of Acute Care Services & Other Major Drivers.” The analysis delves into Tenet Healthcare‘s third-quarter 2024 earnings, showcasing a significant 15% increase in adjusted EBITDA to $978 million and a notable $5.1 billion in net operating revenues. Highlighting key growth drivers, the report emphasizes USPI’s robust growth, marked by an 8.7% revenue increase in its facilities. The continued expansion and strategic partnerships, such as the joint venture in San Diego, add to the positive outlook on Tenet Healthcare‘s growth trajectory.
A look at Tenet Healthcare Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 1 | |
| Growth | 5 | |
| Resilience | 2 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Tenet Healthcare shows a positive long-term outlook. With a high growth score of 5, the company is projected to experience strong expansion in the future. This indicates potential for increased profitability and market share. Additionally, a value score of 3 suggests that the company is reasonably priced compared to its intrinsic value, which may attract investors looking for undervalued opportunities. Although the dividend score is low at 1, the company’s resilience score of 2 implies a moderate ability to weather economic challenges. Momentum score of 3 indicates a stable performance trend. Overall, Tenet Healthcare presents a promising outlook for long-term growth and value.
Tenet Healthcare Corporation, a provider of healthcare services in the United States, operates a variety of facilities including general hospitals, specialty hospitals, psychiatric facilities, and medical office buildings. The company’s diversified portfolio of healthcare services positions it well to meet the needs of various communities across the nation. With a focus on delivering quality care and expanding its offerings, Tenet Healthcare aims to continue growing its presence in the healthcare industry. By leveraging its strong growth potential and overall resilience, the company is poised to capture opportunities for future success and value creation.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
